Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • US debt crisis: Joe Biden gets the deal done but at a cost
    • White House reaches deal with Republicans to avert US debt default
    • China’s first passenger jet completes maiden commercial flight
    • Saudi crown prince turns to ‘state capitalism’ after change in the guard
    • Saudi Arabia in talks to join China-based ‘Brics bank’
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Companies
      Sections
      • Companies Home
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
      Most Read
      • Sky to cut hundreds of jobs in shift from satellite TV
      • Canada’s big banks log 13-fold rise in loan loss provisions
      • UK mid-market dining chains fight for survival after Covid and cost of living woes
      • Peter Orszag: the ‘scholar-banker’ named to restore Lazard’s fortunes
      • Beverly Hills voters reject LVMH luxury hotel on Rodeo Drive
    • Tech
    • Markets
      Sections
      • Markets Home
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
      Most Read
      • Weddings and divorce: the scourge of investment returns
      • AI boom drives gains for chip stocks
      • Investors expect higher interest rates as inflation pressures mount
      • Is COP28 destined to be a flop?
      • India’s biggest alternative asset manager bets on private credit
    • Climate
    • Opinion
      Sections
      • Opinion Home
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
      Most Read
      • Buffett’s intriguing bet on Japan
      • Weddings and divorce: the scourge of investment returns
      • What we get wrong about ageing and work
      • A stylist, yes, but Martin Amis was also right on the money
      • Citizens’ juries can help fix democracy
    • Work & Careers
      Sections
      • Work & Careers Home
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      Most Read
      • Wellcome Leap’s Regina Dugan: ‘Odds are irrelevant, if what you’re trying to do is important’
      • Germany’s tangled relationship with Russia
      • Economist Daniel Chandler: ‘Shareholders have all the power. It doesn’t have to be that way.’
    • Life & Arts
      Sections
      • Life & Arts Home
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
      Most Read
      • Yes, Suella Braverman should go, but not for the reason you think
      • GCHQ’s Jeremy Fleming: ‘Xi doesn’t want to see Putin humiliated’
      • The UK’s best bakeries: the readers’ picks
      • From Bowie to Jagger, the photos that created legends
      • We need to talk about picnics
    • HTSI
    MenuSearch
    • Home
    • World
    • US
    • Companies
    • Tech
    • Markets
    • Climate
    • Opinion
    • Work & Careers
    • Life & Arts
    • HTSI
    Financial Times
    SubscribeSign In

    Disease control and prevention

    Add to myFT Digest

    Add this topic to your myFT Digest for news straight to your inbox

    • Friday, 26 May, 2023
      Covid-19 vaccines
      Brussels and Pfizer agree deal to cut supply of Covid vaccines

      Revised contract addresses concerns over costly glut of unwanted shots as public health threat wanes

    • Wednesday, 24 May, 2023
      Biotech
      UK to announce funding boost for life sciences

      Government seeks to win over pharma groups with new investments in genomics research and drug manufacturing

    • Wednesday, 24 May, 2023
      The FT ViewThe editorial board
      Investors can play their part in the war on superbugs

      As McDonald’s is targeted, governments also need to tighten and enforce rules

    • Wednesday, 24 May, 2023
      Medical science
      AI-based ‘digital bridge’ enables paraplegic patient to walk

      Neurotechnology restores natural gait with device that decodes brain’s signals for people with spinal injuries

    • Wednesday, 24 May, 2023
      Special ReportFT Health Centre
      FT Health: Future of Antibiotics

      The FT examines the causes and effects of an increasing global resistance to antibiotics: from the pressures doctors are under to prescribe them, to what new treatments are currently in the pipeline, as well as what role can the consumer play in reducing antibiotic use in the food chain

    • Tuesday, 23 May, 2023
      Anjana Ahuja
      New surgical procedure makes us question what it means to be alive

      The organ recovery technique has provoked criticism from within the scientific community

    • Friday, 19 May, 2023
      LexAgeing Populations
      Longevity start-ups: hefty funding fails to find fount of youth Premium content

      Human life appears to have an upper limit that has yet to be extended

    • Wednesday, 17 May, 2023
      The Big Read
      Quick blood tests to spot cancer: will they help or harm patients?

      Investors are pouring billions into companies claiming they can analyse DNA to find the disease early. But some scientists question if they really work

    • Tuesday, 16 May, 2023
      Anjana Ahuja
      The loneliness epidemic threatens our health as well as our happiness

      Our craving for human company causes psychological stress, which induces physiological effects

    • Monday, 15 May, 2023
      Mental health
      Happiness levels in UK fail to recover to pre-pandemic norm as prices surge

      Mental health has deteriorated since 2019 with young impacted most, data shows

    • Sunday, 14 May, 2023
      Dementia
      Japan pushes for strong pledges on tackling dementia from G7 allies

      Alzheimer’s advocates call for ambitious declaration to match the scope of commitments made 10 years ago

    • Sunday, 14 May, 2023
      Novavax Inc
      Cash-strapped Novavax urges governments to honour Covid jab deals

      US biotech group is among coronavirus vaccine makers struggling with reduced demand post-pandemic

    • Friday, 12 May, 2023
      UK politics & policy
      ‘Cultural sniffiness’ over profit is hurting NHS drug trials, Labour warns

      Shadow health secretary sets out plan to boost clinical research

    • Friday, 12 May, 2023
      Simon Schama
      The thwarting of science will always be a human failing

      From India to Britain, we have always managed to get in the way of our own inventiveness

    • Thursday, 11 May, 2023
      Mpox
      Mpox is no longer a global health emergency, says WHO

      Viral disease previously known as monkeypox has caused more than 87,000 infections and 140 deaths

    • Thursday, 11 May, 2023
      Science
      Study reveals scale of ‘science scam’ in academic publishing

      One in 5 biomedical articles may contain faked data, with Chinese paper mills leading way

    • Wednesday, 10 May, 2023
      Genomics
      Expanded ‘pan-genome’ database aims to improve treatment of diseases

      Project discovers more variation in DNA than expected, offering insights into human diversity

    • Tuesday, 9 May, 2023
      Janan Ganesh
      The west’s handling of the pandemic beat its own expectations

      A demonised elite produced vaccines and furloughs while a supposedly rebellious public mostly followed the rules

    • Monday, 8 May, 2023
      Dementia
      Two Alzheimer’s drugs offer hope to patients after decades of waiting

      In clinical trials, the medications slowed the progress of the degenerative disease that affects 50mn worldwide

    • Friday, 5 May, 2023
      Coronavirus
      WHO says Covid-19 emergency is over

      UN health body declares end to acute phase of pandemic after at least 20mn deaths

    • Friday, 5 May, 2023
      Wellcome Trust
      Wellcome Trust to triple size of Cambridge genome campus

      Biggest biomedical charity makes first investment in science infrastructure from its endowment

    • Wednesday, 3 May, 2023
      Europe Express
      What the EU learned from panic-buying Covid vaccines Premium content

      Also in this newsletter: Should an American economist lead EU competition policy?

    • Monday, 1 May, 2023
      Noubar Afeyan
      Moderna co-founder calls on US politicians and judges to stop questioning science

      Noubar Afeyan says court rulings on abortion pills and access to healthcare undermine efforts to combat diseases

    • Sunday, 30 April, 2023
      Covid-19 vaccines
      BioNTech/Pfizer’s mooted EU deal for 70mn Covid shots threatens rivals

      European health officials have advocated portfolio diversity to help fight different variants

    • Friday, 28 April, 2023
      Special Report
      The Americas’ Fastest Growing Companies

      The FT’s fourth annual ranking of the region’s businesses by revenue growth. Plus: companies with the ‘last-mover advantage’; cannabis corporations on the rise; is Moderna a one trick pony?

    Previous page You are on page 1 Next page

    Be part of FT Community

    Discover unmissable flagship events and members only communities to expand your thinking and elevate your career

    FT Live
    Transforming Approaches to Triple-Negative Breast Cancer
    Raising awareness, innovating treatments and improving patient support
    Thursday, 8th JuneOnline
    FT Live
    Health Technology Summit
    Transforming Life Sciences & Digitising Healthcare
    Thursday, 30th NovemberOnline
    Learn more about FT Community

    Useful links

    Support

    View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

    Legal & Privacy

    Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

    Services

    Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT ChannelsFT Schools

    Tools

    PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

    Community & Events

    FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

    More from the FT Group

    Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
    The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
    Financial Times

    International Edition

    Subscribe for full access
    • Switch to UK Edition

    Top sections

    • Home
    • World
      • Global Economy
      • UK
      • US
      • China
      • Africa
      • Asia Pacific
      • Emerging Markets
      • Europe
      • War in Ukraine
      • Americas
      • Middle East & North Africa
      • Australia & NZ
    • US
      • US Economy
      • US Companies
      • US Politics & Policy
    • Companies
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
    • Tech
    • Markets
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
    • Climate
    • Opinion
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
    • Work & Careers
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
    • Life & Arts
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
    • Personal Finance
      • Property & Mortgages
      • Investments
      • Pensions
      • Tax
      • Banking & Savings
      • Advice & Comment
      • Next Act
    • HTSI
    • Special Reports

    FT recommends

    • Lex
    • Alphaville
    • Lunch with the FT
    • FT Globetrotter
    • #techAsia
    • Moral Money
    • Newsletters
    • Video
    • Podcasts
    • News feed
    • FT Live Events
    • FT Forums
    • Board Director Programme
    • myFT
    • Portfolio
    • Today's Newspaper (ePaper)
    • Crossword
    • Our Apps
    • Help Centre
    • Subscribe
    • Sign In